| Popis: |
Yubin Tian,1,2,* Yong Zhou,2,* Junhui Liu,1,2 Lei Yi,2 Zhaojia Gao,2,3 Kai Yuan,1,3 Jichun Tong2,3 1School of Medical, Dalian Medical University, Dalian, Peopleâs Republic of China; 2The Affiliated Changzhou No.2 Peopleâs Hospital of Nanjing Medical University, Changzhou, Peopleâs Republic of China; 3Heart and Lung Disease Laboratory, The Affiliated Changzhou No.2 Peopleâs Hospital of Nanjing Medical University, Changzhou, Peopleâs Republic of China*These authors contributed equally to this workCorrespondence: Kai Yuan; Jichun Tong, Email yuankai202001@163.com; tongjichun2012@163.comPurpose: To investigate the expression profile of systemic RNA interference deficient-1 transmembrane family member 1 (SIDT1) in patients with non-small cell lung cancer (NSCLC) and assess its prognostic value and immune infiltration.Materials and Methods: A tissue microarray (TMA) was purchased containing 60 paired NSCLC tissues and matched para-tumor tissues, and another TMA was constructed comprising 140 NSCLC tissues. Then, immunohistochemical staining and scoring were performed. Finally, we evaluated the expression profiles and prognostic values of SIDT1 in NSCLC. Correlation between SIDT1 gene expression and the immune microenvironment of NSCLC was investigated using the ESTIMATE and CIBERSORT algorithms.Results: SIDT1 was mainly detected in the cytoplasm and the cell membrane. SIDT1 expression was significantly higher in tumor tissues than in para-tumor tissues. High expression of SIDT1 was correlated with the NSCLC stage. High SIDT1 expression signals worsening overall survival (OS) in NSCLC patients, especially in stage I. In LUSC, high SIDT1 expression is an independent prognostic factor for worsening OS.Conclusion: High SIDT1 expression predicted a low survival rate in LUSC patients, suggesting it may be a potential target for prognostic assessment of NSCLC patients.Keywords: NSCLC, prognosis, TMA, immune infiltration, SIDT1 |
